Look at paulamichelle's tweet below yours. IP transfer from IBIO to DONG-st for anti HGH. Anti HGH is a tumor reducer & can compete w/cancer bio similar herceptin. IBIO is selling it or trading this to DONG. Nothing about BO or merger but you don't typically hand over IP for anti tumor growth especially when trying to raise capital. Check celtronbiousa.com That's all I can pass on right now and sadly my 3rd and last tweet for the day!
News 
Market Data 
Discover 
AI
